SOLU-CORTEF Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Solu-cortef, and when can generic versions of Solu-cortef launch?
Solu-cortef is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in SOLU-CORTEF is hydrocortisone sodium succinate. There are sixty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocortisone sodium succinate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SOLU-CORTEF?
- What are the global sales for SOLU-CORTEF?
- What is Average Wholesale Price for SOLU-CORTEF?
Summary for SOLU-CORTEF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 94 |
| Clinical Trials: | 37 |
| Patent Applications: | 3,242 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for SOLU-CORTEF |
| What excipients (inactive ingredients) are in SOLU-CORTEF? | SOLU-CORTEF excipients list |
| DailyMed Link: | SOLU-CORTEF at DailyMed |
See drug prices for SOLU-CORTEF
Recent Clinical Trials for SOLU-CORTEF
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of North Carolina, Chapel Hill | Phase 4 |
| University Medical Center Groningen | Early Phase 1 |
| Beth Israel Deaconess Medical Center | Phase 2 |
Pharmacology for SOLU-CORTEF
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for SOLU-CORTEF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | SOLU-CORTEF | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 009866-004 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmacia And Upjohn | SOLU-CORTEF | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 009866-003 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmacia And Upjohn | SOLU-CORTEF | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 009866-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmacia And Upjohn | SOLU-CORTEF | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 009866-002 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
